Goldman Sachs’s Agilon Health AGL Stock Holding History
Bought
Maintained
Sold
Other funds holding AGL
Goldman Sachs's AGL Position: Q3 2026 in Review
Goldman Sachs reduced its Agilon Health (AGL) stake by 4.5% in Q3 2026, selling an estimated $3M and leaving 655,931 shares worth $52.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1669.
Goldman Sachs first reported a position in AGL in Q3 2021 and has held it in 21 quarters since. The position peaked at $73.6M in Q2 2026. 172 funds tracked by Wall St. Rank hold AGL as of Q3 2026.
- Goldman Sachs held 655,931 shares of Agilon Health worth $52.2M as of Q3 2026.
- Goldman Sachs sold 30,861 Agilon Health shares in Q3 2026, an estimated $3M.
- Agilon Health made up ﹤0.01% of Goldman Sachs's portfolio in Q3 2026, its #1669 holding.
- Goldman Sachs first reported a position in Agilon Health in Q3 2021 and has held it in 21 quarters since.
- Goldman Sachs's Agilon Health position peaked at $73.6M in Q2 2026.
- 172 funds tracked by Wall St. Rank held Agilon Health as of Q3 2026.
Based on Goldman Sachs's 13F filing for Q3 2026, filed 16 Nov 2026.